Progesterone for Maintenance Tocolysis: A Randomized Placebo Controlled Trial
Stopped early · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Pregnancy Complications
In brief
Preterm delivery is the most common cause of infant morbidity and mortality in the United States. Some women have episodes of preterm labor during their pregnancy which can be temporarily stopped. These women, however, are at high risk for delivering before term. At this time, we do not have sufficient evidence to use any medication to help prevent these women from delivering early. Recently, preliminary studies have shown that progesterone may help prevent some women at high risk for preterm delivery from delivering early. Our study will investigate whether progesterone can help this specific group of women, women with arrested preterm labor, deliver healthy infants at term.
Key facts
- Study ID
- NCT00946088
- Run by
- Stanford University
- People needed
- 7
- Starts
- 2009-10-01
- Expected to finish
- 2015-03-01
- Last updated by the study team
- 2017-03-16
Who can join
Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.